Someone put a comment on one of the posts I made about the number of School shooters that are on Psychiatric drugs and linked to this site. I checked out the site and while I knew these antidepressants are bad news, I wasn't aware that anyone had documented it to such a degree. Here are more than 1500 stories of antidepressant related violence. And we're not talking shouting when talk violence, no here are murderers and more. It's amazing that with all this - nobody does anything to take them off the market.
There are real solutions to problems of life and none of them involve drugs or electro-shocks or lobotomies. Click here for a good bunch of real solutions. And click here for more facts on the harm Psychiatry does daily.
Check out these stories for yourself.
SSRI Stories
This website is a collection of 1500+ news stories with the full media article available, mainly criminal in nature, that have appeared in the media or that were part of FDA testimony in either 1991, 2004 or 2006, in which antidepressants are mentioned. These stories have been collected over a period of years by two directors of the International Coalition for Drug Awareness (ICFDA). They experienced firsthand the drugs' power to harm and want to save others from the fate that befell them. Their focus has been on Selective Serotonin Reuptake Inhibitors (SSRIs), of which Prozac was the first, launched in December 1987. Other SSRIs are Zoloft, Paxil (Seroxat), Celexa, Sarafem (Prozac in a pink pill), Lexapro, and Luvox. These drugs are widely employed as first line treatment for depression. Other antidepressants included in this list are Remeron, Anafranil and the SNRIs Effexor, Serzone and Cymbalta as well as the dopamine reuptake inhibitor antidepressant Wellbutrin (also marketed as Zyban).
Wednesday, April 25, 2007
Cho was just one in 1500
Labels:
anti psychiatry,
antidepressants,
cchr,
celexa,
cho,
cymbalta,
lexapro,
luvox,
paxil,
prozac,
seroxat,
serzone,
ssri,
virginia tech,
wellbutrin,
zyban
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment